MedPath

Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation

Completed
Conditions
Pulmonary Hypertension
Mitral Valve Regurgitation
Registration Number
NCT03154034
Lead Sponsor
University Hospital Regensburg
Brief Summary

The purpose of this study is the evaluation of cardiac and pulmonary response to cardiopulmonary exercise in severe mitral regurgitation and its variation under treatment (surgical mitral valve repair, percutaneous mitral valve repair, optimal medical treatment). The study is conducted as a prospective, observational, single-center study. Patients suffering from symptomatic severe mitral regurgitation will be eligible, if they are referred to the University Hospital of Regensburg, Germany, for further diagnostic procedures and heart team discussion. Cardiopulmonary exercise testing is performed comprising standardized stress echocardiography as well as ergospirometry. Additional detailed assessment will be conducted including standardized questionary, clinical examination, transesophageal echocardiography and measurement of biomarkers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
38
Inclusion Criteria
  • symptomatic, severe mitral regurgitation
  • referral for diagnostic work-up and heart team discussion
  • declaration of informed consent
Exclusion Criteria
  • contra-indication for cardiopulmonary stress examination (unstable angina pectoris, left main disease, abnormal electrolyte concentrations, acute decompensation)
  • pregnancy
  • exercise test on treadmill not possible (amputation of lower extremity, severe arthritis of lower extremities)
  • no acceptable acoustic window at rest

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
exercise-induced systolic pulmonary arterial pressureChange from Baseline Exercise-Induced Systolic Pulmonary Arterial Pressure at 1 year

exercise-induced systolic pulmonary arterial pressure measured by stress- echocardiography

Secondary Outcome Measures
NameTimeMethod
peak oxygen uptake (peakVO2)Change from Baseline peakVO2 at 1 year

peak oxygen uptake measured by ergospirometry

Trial Locations

Locations (1)

University Hospital Regensburg - Department of Internal Medicine II

🇩🇪

Regensburg, Germany

© Copyright 2025. All Rights Reserved by MedPath